QMS Medical Allied Services Ltd.
QMSMEDI.NS · National Stock Exchange of India · INR
170,28INR
−3,86 (−2,22 %)Stand 9. Nov., 9:17
Kennzahlen
- Eröffnung
- 177,00
- Vortag
- 174,14
- Tagesspanne
- 168,10 – 178,75
- 52 Wochen
- 68,95 – 216,79
- Volumen
- 60
- Ø Volumen
- 41.671
- Börsenwert
- 3,29 Mrd. INR
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 0,7
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Gewinn je Aktie · Erwartet |
|---|
| Gewinn je Aktie · Tatsächlich |
| Abweichung |
| Umsatz · Tatsächlich |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 23. Sept. 2026 | 5. Okt. 2026 | 0,50 |
| 22. Sept. 2025 | 4. Okt. 2025 | 0,50 |
| 20. Sept. 2024 | 2. Okt. 2024 | 0,45 |
| 18. Sept. 2023 | 30. Sept. 2023 | 0,45 |
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
–
Über das Unternehmen
QMS Medical Allied Services Ltd. operates within the healthcare and healthcare equipment and supplies industries in India, focusing on the marketing, distribution, and manufacturing of medical products and the provision of healthcare services. The company distributes medical and healthcare devices, including those from other brands and its own brand, "Q Devices," which encompasses glucometers, pulse oximeters, IR thermometers, BP monitors, orthopedic aids, and pain management solutions. It also manages an e-commerce platform, QMSMEDS, for healthcare device sales. Beyond product distribution, QMS Medical Allied Services offers a range of diagnostic and patient management services, such as ambulatory blood pressure tracking, continuous blood glucose monitoring, and patient screening programs for chronic conditions like diabetes and osteoporosis. These services often involve organizing health camps and patient support programs on behalf of pharmaceutical companies. Additionally, the company provides medical education services through its "Educamedics" division, offering customized scientific content via conferences, online courses, and webinars. Its target markets include clinics, pharmaceutical and medical companies, hospitals, doctors, and individual users across India.
- CEO
- Mahesh Pahalraj Makhija
- Mitarbeitende
- 1.037
- Hauptsitz
- Mumbai, MA, IN
- Sektor
- Healthcare
- Branche
- Medical - Distribution
- Börsengang
- 11. Okt. 2022
- Website
- qmsmas.com/investor
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.